Students and Faculty in the Department of Toxicology and Cancer Biology held an Open House in August to meet with incoming first year graduate students. Oral and poster presentations highlighted the varied research programs in the department that investigate basic, translational and clinical aspects of toxicology and cancer biology.

The Exatherm Total Body Hyperthermia System heats the patient’s blood to potentially damage or kill lung cancer cells throughout the body. UK is the only site in the country approved to test this new treatment in advanced lung cancer patients.

The University of Kentucky Saha Cardiovascular Research Center has selected four students committed to futures in cardiovascular health as the recipients of the 2015 Saha Awards for Cardiovascular Research and Education. Second-year University of Kentucky medical student Kristin Andres earned the 2015 recipient of the medical student honor.

Congratulations to our new UK AOA inductees; including our very own Dustin Stevens!

LEXINGTON, Ky. (Aug. 28, 2015) – The Food and Drug Administration (FDA) approved clinical trials for an investigational cancer treatment pioneered by University of Kentucky researchers in the Department of Surgery.
The Exatherm Total Body Hyperthermia System (Exatherm-TBH) was developed at UK in a public-private partnership with Exatherm, LLC, explained medical researcher Cherry Ballard-Croft, Ph.D. The project received grant funding from the National Institutes of Health.

T.J. Samson Community Hospital in Glasgow, Ky., announced that it has entered into a formal collaboration with the University of Kentucky Markey Cancer Center to further develop its oncology service line. “At T.J. Samson we have wonderful medical professionals that are excellent at providing individualized treatment options. By collaborating with the Markey Cancer Center, we have just provided them a whole new world of resources to offer their patients locally,” Bud Wethington, CEO/President of T.J.

A Postdoctoral position is available in the laboratory of Dr. Nikolova-Karakashian in the Department of Physiology at the UK College of Medicine.  The person fulfilling this position will be involved in mentored research on the role of sphingolipids in hepatic inflammation, as it relates to aging and liver disease. 

 A recent Ph.D in any ares of cellular/molecular biology and 0 to 1 years of experience is required. 

Chellgren Center Names 36 New Fellows, Five Endowed Professorships